Least developed countries vs Saudi Arabia: Immunization, Hib3
Immunization, Hib3 over time
- Least developed countries
- Saudi Arabia
How they compare
Saudi Arabia currently reports 97.0% against 74.4% in Least developed countries, a difference of 22.6%.
That makes Saudi Arabia's figure about 1.3 times Least developed countries's.
Across all 23 years both countries report, Saudi Arabia has been ahead every year.
Least developed countries ranks 30th and Saudi Arabia ranks 29th of 43 groups.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Least developed countries | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 21.0% | 96.2% | 75.3% | Saudi Arabia |
| 2010s | 75.5% | 97.6% | 22.1% | Saudi Arabia |
| 2020s | 74.4% | 96.8% | 22.4% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Least developed countries or Saudi Arabia?
- Saudi Arabia, at 97.0% against 74.4% in Least developed countries as of 2024.
- What is the difference in immunization, hib3 between Least developed countries and Saudi Arabia?
- 22.6%, with Saudi Arabia ahead.
- How many years of comparable data are there for Least developed countries and Saudi Arabia?
- 23 years are reported by both, from 2002 to 2024.
- How do Least developed countries and Saudi Arabia rank globally for immunization, hib3?
- Least developed countries ranks 30th and Saudi Arabia ranks 29th of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.